|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$4,272,804
|
N/A
|
National Cancer Institute
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
1R01CA173481-01A1
|
$389,781
|
$389,781
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-15
|
$685,776
|
$685,776
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
5U01CA141535-05
|
$377,353
|
$377,353
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Estrogen-ERbeta Axis In Disparity of Prostate Cancer
|
5U01CA149204-03
|
$228,392
|
$228,392
|
ABDEL-MAGEED, ASIM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
2R01CA123484-06A1
|
$280,943
|
$280,943
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY MED CTR
|
|
Prostate Cancer Recurrence: models and mechanisms
|
5R01CA167966-02
|
$343,891
|
$343,891
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY MED CTR
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
5R01CA109339-09
|
$280,397
|
$280,397
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-03
|
$1,113,511
|
$100,216
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
Prostate Cancer Prevention and Treatment by Silibinin
|
5R01CA102514-10
|
$303,143
|
$303,143
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Small molecule antagonists of relaxin receptor
|
1U01CA177711-01
|
$297,403
|
$297,403
|
Agoulnik, Alexander
|
FLORIDA INTERNATIONAL UNIVERSITY
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-05
|
$1,806,651
|
$1,806,651
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Resveratrol-Zinc Combination for Prostate Cancer
|
1R21CA176867-01
|
$196,403
|
$196,403
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-03
|
$274,795
|
$274,795
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$1,778
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$20,801
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,539,189
|
$153,919
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$277,628
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
SELECT and Prostate Cancer Prevention Trial (PCPT)
|
ZIA CP010221-10405
|
$222,384
|
$222,384
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$4,500
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Addressing Prostate Cancer Information Disparities with eHealth Technology
|
1R21CA178296-01
|
$241,423
|
$241,423
|
ALLEN, JENNIFER
|
TUFTS UNIVERSITY BOSTON
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-44S1
|
$116,998
|
$10,530
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-05
|
$1,131,982
|
$1,131,982
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-44
|
$2,308,335
|
$207,750
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Maryland Prostate Cancer Case-Control Study
|
ZIA BC 010499
|
$417,731
|
$417,731
|
Ambs, Stefan
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$238,703
|
$238,703
|
Ambs, Stefan
|
CCR (NCI)
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIA BC 010886
|
$59,676
|
$59,676
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$35,413
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Evaluating the role of Thrombospondin-1-CD47 mediated nitric oxide signaling in t
|
1F31CA174096-01A1
|
$28,498
|
$9,689
|
Amend, Sarah
|
WASHINGTON UNIVERSITY
|
|
LTG_Amundadottir
|
ZIA CP010201-10569
|
$554,831
|
$166,449
|
Amundadottir, Laufey
|
DCEG (NCI)
|
|
Angiogenin-induced RNA cleavage in cancer
|
1R01CA168872-01A1
|
$356,063
|
$178,032
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Predicting Prostate Cancer Aggressiveness
|
5U01CA151924-03
|
$524,496
|
$524,496
|
Anderson, Alexander
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$318,741
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)
|
5U54CA143803-05
|
$2,479,751
|
$595,140
|
Austin, Robert
|
PRINCETON UNIVERSITY
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$43,539
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
|
5R01CA140734-03
|
$295,754
|
$295,754
|
Ayala, Gustavo
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
1R21CA172892-01
|
$276,331
|
$69,083
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
2U10CA052667-23
|
$573,647
|
$68,838
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Psycho-sociocultural factors influencing cancer pain management in elderly adults
|
5K01CA131722-05
|
$140,069
|
$35,017
|
Baker, Tamara
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
|
5R01CA075080-15
|
$277,527
|
$138,764
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
1P01CA163227-01A1
|
$2,183,516
|
$2,183,516
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-15
|
$699,208
|
$139,842
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Prevention of prostate cancer growth by a plant alkaloid
|
5R01CA131123-05
|
$299,402
|
$299,402
|
BANERJEE, PARTHA
|
GEORGETOWN UNIVERSITY
|
|
Trends in Surveillance for Localized Prostate Cancer and Barriers to its Use
|
1R03CA173812-01
|
$78,000
|
$78,000
|
Barocas, Daniel
|
VANDERBILT UNIVERSITY MED CTR
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$35,214
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Hypogonadism and Pain Perception in Androgen-Deprived Men with Prostate Cancer
|
1R21CA171316-01A1
|
$243,852
|
$243,852
|
Basaria, Shehzad
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Instrumental Variable Methods for Censored Cost Data and an Application in Prosta
|
5R01CA155329-03
|
$415,371
|
$415,371
|
BASU, ANIRBAN
|
UNIVERSITY OF WASHINGTON
|
|
Novel deregulated genes in the etiology and progression of human prostate cancer
|
3R01CA138791-04S1
|
$44,583
|
$44,583
|
Batra, Surinder
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Novel deregulated genes in the etiology and progression of human prostate cancer
|
5R01CA138791-04
|
$336,747
|
$336,747
|
Batra, Surinder
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Epithelial/stromal signaling in bladder and prostate cell proliferation
|
5R01CA157877-03
|
$329,437
|
$164,719
|
BEACHY, PHILIP
|
STANFORD UNIVERSITY
|
Total relevant funding to Prostate for this search: $255,612,921
|